COVID-19实验室诊断:当前问题与挑战
该评论性文章围绕SARS-CoV-2实验室诊断的分析前、分析中与分析后阶段,讨论标本采集、人员安全、RT-PCR与抗体检测定位及结果解读等关键问题,并指出即时检测整合设备有助于快速诊断与疫情控制。
要点
- 分析前阶段需在正确时间从正确解剖部位采集合格呼吸道标本。
- 分析阶段实时RT-PCR仍是病原学诊断首选,抗体检测作为补充工具。
- 分析后阶段需结合分子与血清学结果谨慎解读检测结果。
核心结论
- SARS-CoV-2感染的实验室诊断需覆盖分析前、分析中与分析后全流程,并重视结果解读与人员安全。
研究设计与样本
- 本文为评论性文章,讨论COVID-19实验室诊断的当前问题与挑战。
主要发现
- 分析前阶段,正确时间、正确解剖部位采集合格呼吸道标本对及时准确的分子诊断至关重要。
- 分析阶段,实时RT-PCR仍是SARS-CoV-2感染病原学诊断的分子检测首选,抗体技术作为补充工具引入。
- 分析后阶段,检测结果应结合分子与血清学发现谨慎解读。
- 即时、随机访问、整合化且具可扩展能力的设备将促进SARS-CoV-2感染的快速准确诊断与监测。
临床怎么用
- 检验科应规范呼吸道标本采集时机与部位,并采取适当措施保障实验室人员安全。
- 以实时RT-PCR作为病原学诊断首选,抗体检测作为补充工具使用。
- 报告解读时结合分子与血清学结果,避免单一结果误判。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
The COVID-19 outbreak has had a major impact on clinical microbiology laboratories in the past several months. This commentary covers current issues and challenges for the laboratory diagnosis of infections caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). In the preanalytical stage, collecting the proper respiratory tract specimen at the right time from the right anatomic site is essential for a prompt and accurate molecular diagnosis of COVID-19. Appropriate measures are required to keep laboratory staff safe while producing reliable test results. In the analytic stage, real-time reverse transcription-PCR (RT-PCR) assays remain the molecular test of choice for the etiologic diagnosis of SARS-CoV-2 infection while antibody-based techniques are being introduced as supplemental tools. In the postanalytical stage, testing results should be carefully interpreted using both molecular and serological findings. Finally, random-access, integrated devices available at the point of care with scalable capacities will facilitate the rapid and accurate diagnosis and monitoring of SARS-CoV-2 infections and greatly assist in the control of this outbreak.
引用
- Tang YW, Schmitz JE, Persing DH, et al. Laboratory Diagnosis of COVID-19: Current Issues and Challenges. J Clin Microbiol. 2020. PMID: 32245835. doi:10.1128/JCM.00512-20
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。